Top asthma drugs in the United States based on revenue in 2011-2012 (in million U.S. dollars)

This statistic represents the top asthma drugs in the United States, based on revenue between July 2011 and June 2012. In this period, the asthma drug Singulair generated around 4.9 billion U.S. dollars of revenues.

Download this statistic as XLS, PPT, PNG and PDF?
Basic Account
  • Access to basic statistics
  • Download as XLS, PPT, PNG and PDF
Premium Account
  • All the advantages of the Basic Account
  • Instant access to all statistics
  • Easy integration into your projects
 Revenue in million U.S. dollars
Singulair 4,940.6
Advair Diskus 4,559.6
Spiriva Handihaler 2,588.8
Combivent 1,131.6
Symbicort 1,131.5
Proair HFA 1,035.5
Flovent HFA 975.4
Budesonide 923.2
Ventolin HFA 655.6
Xolair 591
You may also be interested in...
Show more
Recent Statistics
Related market forecasts
Related Reports
Health & Pharmaceuticals - Statistics & Facts

Find the proper statistic fast and easy: